son of T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Torben Noerup Nielsen who wrote (490)	1/22/2000 9:36:00 PM
From: scaram(o)uche	Read Replies (1) of 673

Poor guy, you're just going to have to try to live with a chart like this, and go without my comments...... iqc.com Everyone shed a tear for Torben. <g> Can comment on the plasma fractionation end of the business, but the thoughts are a couple of years old. Consensus "view out there" is that the fractionation business is low margin, and a source of continuous regulatory nightmares. In addition, there's always been a bunch of BS out there that monoclonals would displace the polyclonal, plasma-derived human immunoglobulin products. Don't know if the complexity of Rh typing has played itself into a clear picture, but..... I lean toward discounting this last criticism. There, happy? Poor, poor Torben! <vbg> Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next